Aqua Bio Technology ASA
Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is b… Read more
Aqua Bio Technology ASA (ABTEC) - Total Assets
Latest total assets as of June 2024: Nkr291.19 Million NOK
Based on the latest financial reports, Aqua Bio Technology ASA (ABTEC) holds total assets worth Nkr291.19 Million NOK as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Aqua Bio Technology ASA - Total Assets Trend (2016–2023)
This chart illustrates how Aqua Bio Technology ASA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Aqua Bio Technology ASA - Asset Composition Analysis
Current Asset Composition (December 2023)
Aqua Bio Technology ASA's total assets of Nkr291.19 Million consist of 20.5% current assets and 79.5% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr4.84 Million | 0.0% |
| Accounts Receivable | Nkr0.00 | 0.0% |
| Inventory | Nkr23.88 Million | 10.1% |
| Property, Plant & Equipment | Nkr17.15 Million | 7.2% |
| Intangible Assets | Nkr41.12 Million | 17.3% |
| Goodwill | Nkr123.47 Million | 51.9% |
Asset Composition Trend (2016–2023)
This chart illustrates how Aqua Bio Technology ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aqua Bio Technology ASA's current assets represent 20.5% of total assets in 2023, a decrease from 90.9% in 2016.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2023, the same as 0.0% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 68.0% of total assets, an increase from 5.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 51.9% of total assets.
Aqua Bio Technology ASA Competitors by Total Assets
Key competitors of Aqua Bio Technology ASA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Aqua Bio Technology ASA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Aqua Bio Technology ASA generates 0.08x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Aqua Bio Technology ASA is currently not profitable relative to its asset base.
Aqua Bio Technology ASA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.60 | 0.33 | 1.17 |
| Quick Ratio | 0.42 | 0.10 | 1.17 |
| Cash Ratio | 0.04 | 0.02 | 0.52 |
| Working Capital | Nkr-59.55 Million | Nkr -22.49 Million | Nkr 517.51K |
Aqua Bio Technology ASA - Advanced Valuation Insights
This section examines the relationship between Aqua Bio Technology ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.72 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 253.8% |
| Total Assets | Nkr237.74 Million |
| Market Capitalization | $7.08 Million USD |
Valuation Analysis
Below Book Valuation: The market values Aqua Bio Technology ASA's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Aqua Bio Technology ASA's assets grew by 253.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Aqua Bio Technology ASA (2016–2023)
The table below shows the annual total assets of Aqua Bio Technology ASA from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | Nkr237.74 Million | +253.77% |
| 2022-12-31 | Nkr67.20 Million | +95.19% |
| 2021-12-31 | Nkr34.43 Million | +112.03% |
| 2020-12-31 | Nkr16.24 Million | +56.34% |
| 2019-12-31 | Nkr10.39 Million | +4.54% |
| 2018-12-31 | Nkr9.94 Million | -79.76% |
| 2017-12-31 | Nkr49.09 Million | -31.27% |
| 2016-12-31 | Nkr71.42 Million | -- |